Invention Grant
- Patent Title: Hydrobromide salt of N-(4-chloro-2-hydroxy-3-((3S)-3-piperidinylsulfonyl)phenyl-N′-(3-Fluoro-2-methylphenyl)urea
-
Application No.: US16218602Application Date: 2018-12-13
-
Publication No.: US10604485B2Publication Date: 2020-03-31
- Inventor: Francis Dominic Sanderson , Sarah Mary Vallance
- Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
- Applicant Address: GB
- Assignee: GlaxoSmithKline Intellectual Property (No.2) Limited
- Current Assignee: GlaxoSmithKline Intellectual Property (No.2) Limited
- Current Assignee Address: GB
- Agent Hao Yin
- Priority: GB1320021.7 20131113
- Main IPC: C07D211/54
- IPC: C07D211/54 ; A61K31/4462
Abstract:
A compound which is the hydrobromide salt of N-{4-chloro-2-hydroxy-3-[(3S)-3-piperidinylsulfonyl]phenyl}-N′-(3-fluoro-2-methylphenyl)urea, compositions, combinations and medicaments containing said compounds and processes for their preparation. The invention also relates to the use of said compounds, combinations, compositions and medicaments.
Public/Granted literature
Information query
